TOP
MarketingGlobal Business Division
Global Business Division
Creating new markets around the world for the benefit of patients who need Taiho's new drugs
Taiho Pharmaceutical's prescription drugs are currently achieving numerous successes, demonstrating their excellent therapeutic effects in medical settings across Asia, the US, and Europe. One such example is the antibiotic Zosyn, which is currently sold in over 90 countries and has been administered to more than 27 million patients. The anticancer agent UFT has grown into a global brand, and is performing very well in the US and Europe. Following UFT, the anticancer agent TS-1 is now being marketed in South Korea, China, Singapore, and Taiwan and was approved in the EU in 2011.
The Global Business Division contributes to inter-national sales by overseeing all activities necessary for obtaining marketing approval and for marketing the company's prescription drugs outside Japan. It is making a great push to bring Taiho's pharmaceuticals to patients worldwide while accelerating efforts in Southeast Asian countries.
The Global Business Division contributes to inter-national sales by overseeing all activities necessary for obtaining marketing approval and for marketing the company's prescription drugs outside Japan. It is making a great push to bring Taiho's pharmaceuticals to patients worldwide while accelerating efforts in Southeast Asian countries.
